208 related articles for article (PubMed ID: 23322778)
1. Temporal transcriptional response during infection of type II alveolar epithelial cells with Francisella tularensis live vaccine strain (LVS) supports a general host suppression and bacterial uptake by macropinocytosis.
Bradburne CE; Verhoeven AB; Manyam GC; Chaudhry SA; Chang EL; Thach DC; Bailey CL; van Hoek ML
J Biol Chem; 2013 Apr; 288(15):10780-91. PubMed ID: 23322778
[TBL] [Abstract][Full Text] [Related]
2. Role of primary human alveolar epithelial cells in host defense against Francisella tularensis infection.
Gentry M; Taormina J; Pyles RB; Yeager L; Kirtley M; Popov VL; Klimpel G; Eaves-Pyles T
Infect Immun; 2007 Aug; 75(8):3969-78. PubMed ID: 17502386
[TBL] [Abstract][Full Text] [Related]
3. Immunologic consequences of Francisella tularensis live vaccine strain infection: role of the innate immune response in infection and immunity.
Cole LE; Elkins KL; Michalek SM; Qureshi N; Eaton LJ; Rallabhandi P; Cuesta N; Vogel SN
J Immunol; 2006 Jun; 176(11):6888-99. PubMed ID: 16709849
[TBL] [Abstract][Full Text] [Related]
4. Francisella tularensis live vaccine strain folate metabolism and pseudouridine synthase gene mutants modulate macrophage caspase-1 activation.
Ulland TK; Janowski AM; Buchan BW; Faron M; Cassel SL; Jones BD; Sutterwala FS
Infect Immun; 2013 Jan; 81(1):201-8. PubMed ID: 23115038
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-6 is essential for primary resistance to Francisella tularensis live vaccine strain infection.
Kurtz SL; Foreman O; Bosio CM; Anver MR; Elkins KL
Infect Immun; 2013 Feb; 81(2):585-97. PubMed ID: 23230288
[TBL] [Abstract][Full Text] [Related]
6. Immune lymphocytes halt replication of Francisella tularensis LVS within the cytoplasm of infected macrophages.
Bradford MK; Elkins KL
Sci Rep; 2020 Jul; 10(1):12023. PubMed ID: 32694562
[TBL] [Abstract][Full Text] [Related]
7. Perforin- and granzyme-mediated cytotoxic effector functions are essential for protection against Francisella tularensis following vaccination by the defined F. tularensis subsp. novicida ΔfopC vaccine strain.
Sanapala S; Yu JJ; Murthy AK; Li W; Guentzel MN; Chambers JP; Klose KE; Arulanandam BP
Infect Immun; 2012 Jun; 80(6):2177-85. PubMed ID: 22493083
[TBL] [Abstract][Full Text] [Related]
8. Lung CD4-CD8- double-negative T cells are prominent producers of IL-17A and IFN-gamma during primary respiratory murine infection with Francisella tularensis live vaccine strain.
Cowley SC; Meierovics AI; Frelinger JA; Iwakura Y; Elkins KL
J Immunol; 2010 May; 184(10):5791-801. PubMed ID: 20393138
[TBL] [Abstract][Full Text] [Related]
9. Aged mice display an altered pulmonary host response to Francisella tularensis live vaccine strain (LVS) infections.
Mares CA; Ojeda SS; Li Q; Morris EG; Coalson JJ; Teale JM
Exp Gerontol; 2010 Feb; 45(2):91-6. PubMed ID: 19825409
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of the live attenuated Francisella tularensis vaccine (LVS) in a murine model of disease.
Green M; Choules G; Rogers D; Titball RW
Vaccine; 2005 Apr; 23(20):2680-6. PubMed ID: 15780452
[TBL] [Abstract][Full Text] [Related]
11. Transcriptome analysis of human immune responses following live vaccine strain (LVS) Francisella tularensis vaccination.
Fuller CL; Brittingham KC; Porter MW; Hepburn MJ; Petitt PL; Pittman PR; Bavari S
Mol Immunol; 2007 May; 44(12):3173-84. PubMed ID: 17349694
[TBL] [Abstract][Full Text] [Related]
12. Oral immunization of mice with the live vaccine strain (LVS) of Francisella tularensis protects mice against respiratory challenge with virulent type A F. tularensis.
KuoLee R; Harris G; Conlan JW; Chen W
Vaccine; 2007 May; 25(19):3781-91. PubMed ID: 17346863
[TBL] [Abstract][Full Text] [Related]
13. Identification of Francisella tularensis outer membrane protein A (FopA) as a protective antigen for tularemia.
Hickey AJ; Hazlett KR; Kirimanjeswara GS; Metzger DW
Vaccine; 2011 Sep; 29(40):6941-7. PubMed ID: 21803089
[TBL] [Abstract][Full Text] [Related]
14. A Francisella tularensis live vaccine strain (LVS) mutant with a deletion in capB, encoding a putative capsular biosynthesis protein, is significantly more attenuated than LVS yet induces potent protective immunity in mice against F. tularensis challenge.
Jia Q; Lee BY; Bowen R; Dillon BJ; Som SM; Horwitz MA
Infect Immun; 2010 Oct; 78(10):4341-55. PubMed ID: 20643859
[TBL] [Abstract][Full Text] [Related]
15. An improved vaccine for prevention of respiratory tularemia caused by Francisella tularensis SchuS4 strain.
Bakshi CS; Malik M; Mahawar M; Kirimanjeswara GS; Hazlett KR; Palmer LE; Furie MB; Singh R; Melendez JA; Sellati TJ; Metzger DW
Vaccine; 2008 Sep; 26(41):5276-88. PubMed ID: 18692537
[TBL] [Abstract][Full Text] [Related]
16. Toll-like receptor 2-mediated signaling requirements for Francisella tularensis live vaccine strain infection of murine macrophages.
Cole LE; Shirey KA; Barry E; Santiago A; Rallabhandi P; Elkins KL; Puche AC; Michalek SM; Vogel SN
Infect Immun; 2007 Aug; 75(8):4127-37. PubMed ID: 17517865
[TBL] [Abstract][Full Text] [Related]
17. Generation and characterization of an attenuated mutant in a response regulator gene of Francisella tularensis live vaccine strain (LVS).
Sammons-Jackson WL; McClelland K; Manch-Citron JN; Metzger DW; Bakshi CS; Garcia E; Rasley A; Anderson BE
DNA Cell Biol; 2008 Jul; 27(7):387-403. PubMed ID: 18613792
[TBL] [Abstract][Full Text] [Related]
18. Differential ability of novel attenuated targeted deletion mutants of Francisella tularensis subspecies tularensis strain SCHU S4 to protect mice against aerosol challenge with virulent bacteria: effects of host background and route of immunization.
Conlan JW; Shen H; Golovliov I; Zingmark C; Oyston PC; Chen W; House RV; Sjöstedt A
Vaccine; 2010 Feb; 28(7):1824-31. PubMed ID: 20018266
[TBL] [Abstract][Full Text] [Related]
19. Inactivated Francisella tularensis live vaccine strain protects against respiratory tularemia by intranasal vaccination in an immunoglobulin A-dependent fashion.
Baron SD; Singh R; Metzger DW
Infect Immun; 2007 May; 75(5):2152-62. PubMed ID: 17296747
[TBL] [Abstract][Full Text] [Related]
20. OpiA, a Type Six Secretion System Substrate, Localizes to the Cell Pole and Plays a Role in Bacterial Growth and Viability in
Cantlay S; Haggerty K; Horzempa J
J Bacteriol; 2020 Jun; 202(14):. PubMed ID: 32366588
[No Abstract] [Full Text] [Related]
[Next] [New Search]
